FDA Approved: BELSOMRA — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approved BELSOMRA (suvorexant) as an original application for the treatment of insomnia in adults. BELSOMRA is a dual orexin receptor antagonist that helps …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Belsomra (suvorexant)

Snippet

ORIG AP for BELSOMRA (SUVOREXANT)